APA (7th ed.) Citation

S, M., GD, B., HJ, S., K, W., CD, S., JC, A., . . . PJM, R. (2023). Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders. MAbs, 15(1), 2254676. https://doi.org/10.1080/19420862.2023.2254676

Chicago Style (17th ed.) Citation

S, Maciuba, et al. "Discovery and Characterization of Prolactin Neutralizing Monoclonal Antibodies for the Treatment of Female-prevalent Pain Disorders." MAbs 15, no. 1 (2023): 2254676. https://doi.org/10.1080/19420862.2023.2254676.

MLA (9th ed.) Citation

S, Maciuba, et al. "Discovery and Characterization of Prolactin Neutralizing Monoclonal Antibodies for the Treatment of Female-prevalent Pain Disorders." MAbs, vol. 15, no. 1, 2023, p. 2254676, https://doi.org/10.1080/19420862.2023.2254676.